TY - JOUR
T1 - Age at HPV vaccine initiation and completion among US adolescent girls
T2 - Trend from 2008 to 2012
AU - Rahman, Mahbubur
AU - McGrath, Christine J.
AU - Hirth, Jacqueline M.
AU - Berenson, Abbey B.
N1 - Funding Information:
Dr. McGrath and Dr. Hirth are supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women's Health Program – BIRCWH, PI: Berenson) from the Office of Research on Women's Health (ORWH), the Office of the Director (OD), the National Institute of Allergy and Infectious Diseases (NIAID), and NICHD at the National Institutes of Health.
Publisher Copyright:
© 2014 Elsevier Ltd.
PY - 2015/1/29
Y1 - 2015/1/29
N2 - Objective: To examine the trend of provider-verified HPV vaccine initiation (≥1 dose) and completion (≥3 doses) among adolescent girls at the Advisory Committee on Immunization Practices (ACIP) recommended age (11-12 years). Methods: We analyzed National Immunization Survey of Teens 2008-2012 data and examined the trend of provider-verified HPV vaccine initiation and completion among <13 year old girls. Results: Data on age at HPV vaccine initiation and completion were available for 24,466 and 15,972 girls, respectively. The weighted proportion of girls who initiated the vaccine at <13 years of age was 14.1%, 24.1%, 35.9%, 47.7% and 55.9% in 2008, 2009, 2010, 2011 and 2012, respectively (p for trend <.001). The similar trend was also observed for mean age at HPV vaccine initiation and completion (p<. .001). Conclusions: Additional efforts are needed to increase HPV vaccine uptake among adolescent girls as only half of them receive this vaccine at ACIP recommended age.
AB - Objective: To examine the trend of provider-verified HPV vaccine initiation (≥1 dose) and completion (≥3 doses) among adolescent girls at the Advisory Committee on Immunization Practices (ACIP) recommended age (11-12 years). Methods: We analyzed National Immunization Survey of Teens 2008-2012 data and examined the trend of provider-verified HPV vaccine initiation and completion among <13 year old girls. Results: Data on age at HPV vaccine initiation and completion were available for 24,466 and 15,972 girls, respectively. The weighted proportion of girls who initiated the vaccine at <13 years of age was 14.1%, 24.1%, 35.9%, 47.7% and 55.9% in 2008, 2009, 2010, 2011 and 2012, respectively (p for trend <.001). The similar trend was also observed for mean age at HPV vaccine initiation and completion (p<. .001). Conclusions: Additional efforts are needed to increase HPV vaccine uptake among adolescent girls as only half of them receive this vaccine at ACIP recommended age.
KW - Adolescent girls
KW - Age at vaccine completion
KW - Age at vaccine initiation
KW - HPV vaccine
KW - Human papillomavirus (HPV)
UR - http://www.scopus.com/inward/record.url?scp=84921313515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921313515&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2014.12.021
DO - 10.1016/j.vaccine.2014.12.021
M3 - Article
C2 - 25529289
AN - SCOPUS:84921313515
VL - 33
SP - 585
EP - 587
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 5
ER -